Arrevus, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2015-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.arrevus.com
Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients
Phase 2
Completed
- Conditions
- Melioidosis
- Interventions
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT05105035
- Locations
- 🇹🇭
Maharat Nakhonratchasima Hospital, Nai Muang, Thailand
🇹🇭Udon Thani Hospital, Udon Thani, Thailand
🇹🇭Srinagarind Hospital, Khon Kaen University, Nai Muang, Thailand
Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Phase 3
Completed
- Conditions
- Acute Bacterial Skin and Skin Structure Infections
- Interventions
- First Posted Date
- 2015-10-07
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 716
- Registration Number
- NCT02570490
Oral Sodium Fusidate (CEM-102) for the Treatment of Staphylococcal Bone or Joint Infections
- First Posted Date
- 2015-10-06
- Last Posted Date
- 2020-01-30
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02569541
Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
Phase 2
Terminated
- Conditions
- Prosthetic Joint Infections of KneeInfected SpacersProsthetic Joint Infections of Hip
- Interventions
- First Posted Date
- 2012-12-28
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT01756924
Safety and Efficacy of CEM-102 Compared to Linezolid in Acute Bacterial Skin Infections
- First Posted Date
- 2009-07-29
- Last Posted Date
- 2019-04-19
- Lead Sponsor
- Arrevus Inc.
- Target Recruit Count
- 198
- Registration Number
- NCT00948142
© Copyright 2025. All Rights Reserved by MedPath